Esophageal Cancer Immunotherapy Combination Linked to Earlier Adverse Events but Lower Mortality Odds
A pharmacovigilance study reveals combining immune checkpoint inhibitors with chemotherapy brings earlier adverse events alongside lower reported mortality odds than ...








